2023 ETF Series Trust II Files Proxy Materials
| Field | Detail |
|---|---|
| Company | 2023 Etf Series Trust II |
| Form Type | DEFA14A |
| Filed Date | Sep 26, 2025 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 5 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-filing, etf, sec-filing
Related Tickers: QLTY, BCHI, QLTI, GMOI, INVG
TL;DR
2023 ETF Series Trust II dropped proxy docs for GMO ETFs like QLTY & BCHI.
AI Summary
2023 ETF Series Trust II, a Delaware-based entity, filed a DEFA14A on September 26, 2025. This filing concerns proxy materials for the trust, which includes several GMO-branded ETFs such as the GMO U.S. Quality ETF (QLTY) and the GMO Beyond China ETF (BCHI). The filing is related to the trust's operations and shareholder communications.
Why It Matters
This filing provides shareholders of the 2023 ETF Series Trust II with important information regarding their rights and the governance of the ETFs they invest in, such as the GMO U.S. Quality ETF.
Risk Assessment
Risk Level: low — This is a routine proxy filing for an ETF trust and does not indicate unusual financial activity or risk.
Key Players & Entities
- 2023 ETF Series Trust II (company) — Registrant
- GMO U.S. Quality ETF (company) — Underlying ETF
- QLTY (company) — Ticker Symbol for GMO U.S. Quality ETF
- GMO Beyond China ETF (company) — Underlying ETF
- BCHI (company) — Ticker Symbol for GMO Beyond China ETF
- GMO International Quality ETF (company) — Underlying ETF
- QLTI (company) — Ticker Symbol for GMO International Quality ETF
- GMO International Value ETF (company) — Underlying ETF
- GMOI (company) — Ticker Symbol for GMO International Value ETF
- GMO Systematic Investment Grade Credit ETF (company) — Underlying ETF
FAQ
What type of filing is this for 2023 ETF Series Trust II?
This is a DEFA14A filing, which is a Definitive Additional Materials proxy statement filed on September 26, 2025.
What is the primary purpose of a DEFA14A filing?
A DEFA14A filing is used to provide definitive proxy materials to shareholders, typically related to meetings or important corporate actions.
Which ETFs are listed under 2023 ETF Series Trust II?
The filing lists several GMO ETFs including GMO U.S. Quality ETF (QLTY), GMO Beyond China ETF (BCHI), GMO International Quality ETF (QLTI), GMO International Value ETF (GMOI), GMO Systematic Investment Grade Credit ETF (INVG), and GMO U.S. Value ETF (GMOV).
Where is 2023 ETF Series Trust II located?
The trust's business and mailing address is located at 53 State Street, Floor 33, Boston, MA 02109.
What is the SEC file number for 2023 ETF Series Trust II?
The SEC file number for 2023 ETF Series Trust II is 811-23895.
Filing Stats: 1,155 words · 5 min read · ~4 pages · Grade level 9.8 · Accepted 2025-09-26 14:43:18
Filing Documents
- gmoetf-efp17889_defa14a.htm (DEFA14A) — 43KB
- gmo_header.jpg (GRAPHIC) — 28KB
- 0001133228-25-010213.txt ( ) — 84KB
- S000082992
- C000246461 (QLTY)
- S000088547
- C000254839 (BCHI)
- S000088548
- C000254840 (QLTI)
- S000088549
- C000254841 (GMOI)
- S000088550
- C000254842 (INVG)
- S000088551
- C000254843 (GMOV)
From the Filing
EXCHANGE TRADED FUNDS - DEFA 14A UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A SCHEDULE 14A INFORMATION Proxy the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material under §240.14a-12 THE 2023 ETF SERIES TRUST II (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11 INTERNAL USE ONLY GMO TRUST DIRECTOR ELECTION This document is provided to assist GMO relationship managers in answering questions during oral conversations with shareholders of GMO's exchange-traded funds ("ETFs") and their respective advisers, plan-level fiduciaries/representatives and consultants regarding the proposed nominees for Trustees submitted to ETF shareholders. This communication is for internal use only. It should not be distributed in whole or in part to anyone outside of GMO. Summary Timeline September 8 Record date (determines shareholders eligible to vote) September 15 File Proxy Statement September 18-24 Mailing/E-delivery of proxy statement October 15 Last day to submit proxy October 16 Shareholder meeting (1) What is the reason for the election? The purpose of the election is to align the Board of Trustees of the ETFs with the Board of Trustees of GMO's mutual funds. GMO originally launched its ETFs in 2023 using an outsourced model supported by the Goldman Sachs ETF Accelerator platform. Following the news that Goldman Sachs was shutting down its ETF Accelerator business, GMO determined that using an internal support structure for the ETFs, leveraging its existing support model for its mutual fund business, would help streamline GMO's registered fund product suite and promote operational efficiencies and administrative convenience. The decision to transition to an internal support model for the ETFs also reflects GMO's long-term commitment to ETFs and its expectation that ETFs will play an increasingly large role in GMO's overall business. An important part of the transition is an alignment of the Boards of Trustees of the ETFs and mutual funds to create a unified oversight function across GMO's registered funds. Accordingly, ETF shareholders are being asked to elect the current trustees of GMO's mutual funds to serve as trustees of the ETFs as well. (2) What will happen to the existing Trustees of the ETFs? If the nominees are elected by ETF shareholders, the existing Trustees will resign. (3) How does the client vote via proxy? The client can submit their proxy in three different ways: By Internet : using the control number from the email/mailing, go to www.proxyvote.com or scan the supplied QR code. For those that received the proxy via email, click the "vote now" or similar link in the email. By Telephone: using the control number from the email/mailing, call 1-800-690-6903 and follow the prompts. By Mail: for those receiving hard copy mailing, check the appropriate box on the proxy card, sign and date the proxy card, return the proxy card in the envelope provided. (4) Who is entitled to vote? Shareholders as of the record date (September 8, 2025) will be entitled to vote and submit a proxy. All shareholders are strongly encouraged to vote after receipt of the proxy statement and related proxy. (5) How many votes are needed to approve the election of each trustee? The election is being held on a Trust-wide (not Fund-specific) basis. The minimum votes required to be cast in person or by proxy (quorum) is 30%. A nominee will be elected as a trustee if a quorum is achieved and he/she receives a plurality of the votes cast. (6) Who is paying for the costs of the proxy? GMO is bearing the costs of the proxy. 2 Inbound Information Agent Script GMO Exchange Traded Funds Meeting Date: October 16, 2025 Dedicated Toll-Free Number: 855-206-1117 INBOUND GREETING: Thank you for calling the Broadridge Proxy Services Center for the GMO Exchange Traded Funds, you are on a recorded line . My name is <Agent Name>. How may I assist you today? IF UNSURE OF VOTING: Would you like me to review the proposal(s) with you? <Once questions have been answered using the proxy materials provided, review the voting options available.> IF NOT RECEIVED/REQUESTING MATERIAL TO BE RE-MAILED: Mr./Ms. <shareholder's last name>, if you would like to review the proxy statement, GMO Exchange Traded Funds made it easy for you to review online at: https://www.gmo.com/americas/lega